1 Min Read
Sept 22 (Reuters) - Abbott Laboratories
* Abbott secures FDA approval for MRI-compatibility for the company’s Ellipse ICD Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.